Phase 0 pharmacodynamic study of poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with refractory solid tumors and lymphomas: Immunohistochemistry results

被引：3
|
作者：
Yang, S. X.
Kummar, S.
Rubinstein, L.
Gutierrez, M.
Murgo, A. J.
Parchment, R. E.
Nguyen, D.
Chen, A. P.
Tomaszewski, J. E.
Doroshow, J. H.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] SAIC Inc, Frederick, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3580
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modulation of radiation response of non-small cell lung cancer cells with poly (ADP-ribose) polymerase inhibitor: ABT-888
    Hall, W. A.
    Wang, L.
    Clarke, J.
    Otterson, G.
    Wang, J. Z.
    Villalona, M.
    Hoang, T.
    Mayr, N.
    Ross, P.
    Grecula, J. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S709 - S709
  • [32] Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry
    Wiegand, Richard
    Wu, Jianmei
    Sha, Xianyi
    LoRusso, Patricia
    Li, Jing
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (3-4): : 333 - 339
  • [33] A novel Poly(ADP-ribose) polymerase inhibitor, ABT-888, sensitizes malignant human cell lines to ionizing radiation under oxia and hypoxia
    Liu, S. K.
    Coackley, C.
    Bristow, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S615 - S615
  • [34] ABT-888, a poly(adp-ribose) polymerase (PARP) inhibitor, penetrates the cerebrospinal fluid (CSF) after oral administration in nonhuman primates (NHP)
    Muscal, Jodi
    Thompson, Patrick
    Giranda, Vincent
    Bauch, Joy
    Dayton, Brian
    McGuffey, Leticia
    Gibson, Brian
    Horton, Terzah
    Dauser, Robert
    Nuchtern, Jed
    Blaney, Susan
    Su, Jack
    NEURO-ONCOLOGY, 2008, 10 (03) : 508 - 508
  • [35] The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy
    Nowsheen, Somaira
    Bonner, James A.
    Yang, Eddy S.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 (03) : 331 - 338
  • [36] A novel poly (ADP-ribose) polymerase inhibitor, ABT-888, sensitizes malignant human cell lines to ionizing radiation under both oxia and hypoxia
    Liu, S. K.
    Coackley, C.
    Bristow, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S40 - S40
  • [37] Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888; V) in combination with irinotecan (CPT-11; Ir) in patients (pts) with advanced solid tumors.
    LoRusso, P.
    Ji, J. J.
    Li, J.
    Heilbrun, K.
    Shapiro, G.
    Sausville, E. A.
    Boerner, S. A.
    Smith, D. W.
    Pilat, M. J.
    Zhang, J.
    Chen, A. P.
    Nechiporchik, N.
    Parchment, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias
    Karp, Judith E.
    Pratz, Keith W.
    Litzow, Mark R.
    Ji, Juping
    Chen, Alice
    Rudek, Michelle
    Kaufmann, Scott H.
    BLOOD, 2010, 116 (21) : 1342 - 1343
  • [39] A phase I study of ABT-888 (A) in combination with metronomic cyclophosphamide (C) in adults with refractory solid tumors and lymphomas.
    Kummar, S.
    Chen, A. P.
    Ji, J. J.
    Allen, D.
    Egorin, M. J.
    Gandara, D. R.
    Lenz, H.
    Morgan, R.
    Newman, E. M.
    Doroshow, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias
    Pratz, Keith W.
    Kaufmann, Scott H.
    Litzow, Mark R.
    Ji, Jiuping
    Chen, Alice
    Rudek, Michelle A.
    Karp, Judith E.
    BLOOD, 2011, 118 (21) : 1552 - 1552
12345